Clinical Trial Update: Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and efficacy update of bempedoic acid (CLEAR Harmony OLE) completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia

Drugs mentioned

• Bempedoic Acid (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hypercholesterolemia, Atherosclerotic Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-12-22